Adient
ADNT
17.55
+0.04
+0.23%
Adient
US · ADNT
#3061 by market cap
Listed 2016
17.55
+0.04
+0.23%
Live - 5344 symbols - heartbeat 228s ago
· 2026-10-08 04:23
Pre-market
17.49
-0.32%
After-hours
17.55
0.00%
- Market cap
- 1.35B
- P/E (TTM)i
- 31.91
- P/Bi
- 0.78
- EPSi
- -3.39
- Div yieldi
- 0.00%
- 52W posi
- 10%
Reader sentiment
Are you bullish or bearish on ADNT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.78, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -1.04% YoY
Margins
- Gross margin
- 6.61%
- Operating margin
- 3.02%
- Net margin
- -1.93%
Key ratios & quality
- Enterprise valuei
- 2.79B
- Altman Z-Scorei
- 1.78
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 17.44B | 16.53B | 12.67B | 13.68B | 14.12B | 15.40B | 14.69B | 14.54B |
| Gross profit | 904.00M | 801.00M | 592.00M | 826.00M | 807.00M | 1.03B | 928.00M | 961.00M |
| Selling & admin expenses | 730.00M | 671.00M | 558.00M | 537.00M | 598.00M | 554.00M | 507.00M | 522.00M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 174.00M | 130.00M | 34.00M | 289.00M | 209.00M | 479.00M | 421.00M | 439.00M |
| Pretax profit | -1.12B | 2.00M | -429.00M | 1.44B | 54.00M | 295.00M | 133.00M | -88.00M |
| Tax | 480.00M | 410.00M | 57.00M | 249.00M | 94.00M | 0 | 32.00M | 103.00M |
| Net profit | -1.60B | -408.00M | -486.00M | 1.19B | -40.00M | 295.00M | 101.00M | -191.00M |
| Basic EPS | -18 | -5 | -6 | 12 | -1 | 2 | 0 | -3 |
| Diluted EPS | -18.06 | -5.25 | -5.83 | 11.58 | -1.27 | 2.15 | 0.20 | -3.39 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 3.61B | 3.74B | 3.69B | 3.64B | 3.87B | 3.93B |
| Gross profit | 261.00M | 237.00M | 247.00M | 217.00M | 257.00M | 235.00M |
| Selling & admin expenses | 144.00M | 129.00M | 124.00M | 130.00M | 138.00M | 136.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 117.00M | 108.00M | 123.00M | 87.00M | 119.00M | 99.00M |
| Pretax profit | -265.00M | 66.00M | 64.00M | 41.00M | 76.00M | 65.00M |
| Tax | 48.00M | 7.00M | 26.00M | 42.00M | 32.00M | 23.00M |
| Net profit | -313.00M | 59.00M | 38.00M | -1.00M | 44.00M | 42.00M |
| Basic EPS | -4 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -3.99 | 0.43 | 0.22 | -0.28 | 0.34 | 0.32 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 4.31B | 4.12B | 4.48B | 5.09B | 4.16B | 4.32B | 4.09B | 4.13B |
| Cash & ST investments | 687.00M | 924.00M | 1.69B | 1.52B | 947.00M | 1.11B | 945.00M | 958.00M |
| Inventory | 824.00M | 793.00M | 685.00M | 976.00M | 953.00M | 841.00M | 758.00M | 695.00M |
| Total assets | 10.94B | 10.34B | 10.26B | 10.78B | 9.16B | 9.42B | 9.35B | 8.95B |
| Total current liabilities | 4.19B | 3.84B | 3.82B | 3.51B | 3.50B | 3.74B | 3.68B | 3.69B |
| Short-term debt | 8.00M | 30.00M | 210.00M | 184.00M | 14.00M | 134.00M | 9.00M | 11.00M |
| Long-term debt | 3.42B | 3.71B | 4.10B | 3.51B | 2.56B | 2.40B | 2.40B | 2.39B |
| Total liabilities | 8,178,000,000.00 | 8,102,000,000.00 | 8,683,000,000.00 | 7,820,000,000.00 | 6,738,000,000.00 | 6,821,000,000.00 | 6,817,000,000.00 | 6,796,000,000.00 |
| Total equity | 2.76B | 2.24B | 1.58B | 2.96B | 2.42B | 2.60B | 2.53B | 2.16B |
| Retained earnings | -1.03B | -1.55B | -2.10B | -988.00M | -1.11B | -903.00M | -885.00M | -1.17B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 3.89B | 4.02B | 4.13B | 3.92B | 4.25B | 4.19B |
| Cash & ST investments | 754.00M | 860.00M | 958.00M | 855.00M | 831.00M | 924.00M |
| Inventory | 719.00M | 726.00M | 695.00M | 760.00M | 735.00M | 729.00M |
| Total assets | 8.59B | 8.84B | 8.95B | 8.77B | 9.03B | 8.96B |
| Total current liabilities | 3.51B | 3.60B | 3.69B | 3.59B | 3.87B | 3.82B |
| Short-term debt | 10.00M | 9.00M | 11.00M | 11.00M | 9.00M | 9.00M |
| Long-term debt | 2.39B | 2.39B | 2.39B | 2.38B | 2.38B | 2.38B |
| Total liabilities | 6,569,000,000.00 | 6,676,000,000.00 | 6,796,000,000.00 | 6,677,000,000.00 | 6,944,000,000.00 | 6,871,000,000.00 |
| Total equity | 2.02B | 2.16B | 2.16B | 2.10B | 2.09B | 2.09B |
| Retained earnings | -1.22B | -1.18B | -1.17B | -1.19B | -1.16B | -1.14B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 679.00M | 308.00M | 246.00M | 260.00M | 274.00M | 667.00M | 543.00M | 449.00M |
| Depreciation & amortization | 447.00M | 318.00M | 332.00M | 330.00M | 350.00M | 340.00M | 332.00M | 325.00M |
| Free cash flow | 143.00M | -160.00M | -80.00M | 0 | 47.00M | 415.00M | 277.00M | 204.00M |
| Dividends paid | -103.00M | -26.00M | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | 0 | 0 | -65.00M | -275.00M | -125.00M |
| Ending cash balance | 687.00M | 924.00M | 1.69B | 1.52B | 947.00M | 1.11B | 945.00M | 958.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -45.00M | 172.00M | 213.00M | 80.00M | 81.00M | 205.00M |
| Depreciation & amortization | 79.00M | 83.00M | 83.00M | 80.00M | 80.00M | 86.00M |
| Free cash flow | -90.00M | 115.00M | 134.00M | 15.00M | 8.00M | 138.00M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | -50.00M | -50.00M | -25.00M | 0 | -30.00M |
| Ending cash balance | 754.00M | 860.00M | 958.00M | 855.00M | 831.00M | 924.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -50.52 | -23.16 | -35.74 | 61.74 | -5.39 | 9.53 | 0.83 | -14.41 |
| ROA %i | -13.98 | -4.61 | -5.31 | 10.53 | -1.20 | 2.21 | 0.19 | -3.07 |
| ROIC %i | -23.34 | -6.61 | -7.16 | 22.67 | 0.39 | 7.99 | 3.05 | -3.43 |
| 5-year avg ROE %i | -9.48 | -15.23 | -24.04 | -5.39 | -10.61 | 1.40 | 6.19 | 10.46 |
| EBIT margin %i | -5.61 | 1.02 | -1.68 | 12.39 | 1.79 | 3.17 | 2.21 | 0.78 |
| FCF / sales %i | 0.82 | -- | -- | -- | 0.33 | 2.70 | 1.89 | 1.40 |
| Current ratioi | 1.03 | 1.07 | 1.17 | 1.45 | 1.19 | 1.15 | 1.11 | 1.12 |
| Quick ratioi | 0.66 | 0.74 | 0.87 | 0.84 | 0.80 | 0.80 | 0.77 | 0.77 |
| Debt / assetsi | 31.35 | 36.14 | 41.97 | 34.29 | 28.15 | 26.90 | 25.72 | 26.77 |
| LT debt / equityi | 143.06 | 200.65 | 337.76 | 147.81 | 123.69 | 107.76 | 112.28 | 135.11 |
| Interest coveragei | -6.89 | 1.01 | -0.99 | 6.62 | 1.27 | 2.53 | 1.70 | 0.56 |
| Revenue CAGR (3Y) %i | -4.50 | -0.53 | -7.89 | -7.77 | -5.11 | 6.71 | 2.40 | 0.97 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -74.67 | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | 63.12 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -14.33 | -11.85 | -14.41 | -16.78 | 3.51 | 2.73 |
| ROA %i | -2.99 | -2.45 | -3.07 | -3.50 | 0.67 | 0.54 |
| ROIC %i | -3.31 | -2.13 | -3.43 | -4.00 | 4.13 | 3.73 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 0.58 | 0.75 | 0.78 | 0.76 | 3.04 | 2.98 |
| FCF / sales %i | 1.63 | 1.81 | 1.40 | 1.19 | 1.82 | 1.95 |
| Current ratioi | 1.11 | 1.12 | 1.12 | 1.09 | 1.10 | 1.10 |
| Quick ratioi | 0.75 | 0.75 | 0.77 | 0.69 | 0.74 | 0.74 |
| Debt / assetsi | 27.90 | 27.09 | 26.77 | 27.25 | 26.44 | 26.65 |
| LT debt / equityi | 144.43 | 133.61 | 135.11 | 137.18 | 138.88 | 137.59 |
| Interest coveragei | 0.43 | 0.55 | 0.56 | 0.54 | 2.19 | 2.21 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 04:23:57 · For reference only, not investment advice and not tailored to your situation.